Subtype

Female Reproductive System Neoplasm

Non-malignant1,630 active trials11 approved drugs139 evidence items

NCIt: C3053
MeSH: D005833

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (339)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 226–250 of 339 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Phosphorylated HPV‑16 E7 disrupts planar cell polarity in cervical cancer cells through vangl1 dysregulation.
Ifeoluwa D Gbala, Om Basukala, Amira Zine El Abidine et al. · PLoS Pathog · Sep 1, 2026 · PMID 42766580 · candidate dictionary pubmed
Outcomes and Long-term Follow-up of Epithelial Ovarian Cancer: Experience from the Lead Cancer Center of Pakistan.
Jamshed Ali, Mahnoor Raza, Muhammad Umer Khayyam Azam et al. · J Cancer Allied Spec · Mar 1, 2026 · PMID 42683210 · candidate dictionary pubmed
Integrative proteomics reveals MSH6 to modulate PARP inhibitor sensitivity in BRCA1/2-proficient ovarian cancer.
Ou Deng, Thales Da Costa Nepomuceno, Bin Fang et al. · PLoS One · Jan 1, 2026 · PMID 42685115 · candidate dictionary pubmed
Combinatorial Effects of Plasma-Treated Solution and Plasma-Treated Hydrogel with Cisplatin in Vulvar Cancer Cells.
Estelle C I D Schad, Janet P Raja Xavier, Hortense Decool et al. · Oncol Res · Jan 1, 2026 · PMID 42630708 · candidate dictionary pubmed
Women's compliance with cervical cancer screening recommendations and associated barriers to participation: A cross-sectional analysis.
Lauma Spriņģe, Anda Ķīvīte-Urtāne, Ļubova Tihomirova et al. · PLoS One · Jan 1, 2026 · PMID 42721157 · candidate dictionary pubmed
Receptor Co‑targeting Strategies for Personalized Ovarian Cancer Therapy.
Weranga Rajapaksha, Preethi Eldi, Todd A Gillam et al. · Int J Nanomedicine · Jan 1, 2026 · PMID 42732377 · candidate dictionary pubmed

Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer: A Multicenter Real-World Study.

Xingyu Liu, Yiyang Shen, Yingjun Zhao et al. · Int J Womens Health · Jan 1, 2026 · PMID 42733847 · candidate dictionary pubmed

"Even with one Man, but with many women, you can get cervical cancer": Qualitative exploration of women's perceptions and experiences of cervical cancer screening in Uganda: A community-based study.

Robert M Bulamba, Fred Nalugoda, Amanda P Miller et al. · PLOS Glob Public Health · Jan 1, 2026 · PMID 42758761 · candidate dictionary pubmed

Cervical Cancer Survival in Mali: A 21-Year Retrospective Cohort Study of Trends, Determinants, and Outcomes at Gabriel Touré Teaching Hospital (2003-2024).

Fatoumata Korika Tounkara, Abdoulaye Sissoko, Madi Traoré et al. · Obstet Gynecol Int · Jan 1, 2026 · PMID 42757161 · candidate dictionary pubmed

BCAM-AKT2 fusion protein promotes unfolded protein response driven oncogenic signaling in SKOV3 epithelial ovarian cancer cell line.

Hala Khazem, Ravid Solomon Zemler, Liron Vardi David et al. · PLoS One · Jan 1, 2026 · PMID 42789557 · candidate dictionary pubmed

Simultaneous Occurrence of Breast Cancer Metastases and Cervical Cancer Metastases in the Same Lymph Node.

Leonie-Sophia Pösch, Theodora Todorovic, Daniela Hagen et al. · Case Rep Obstet Gynecol · Jan 1, 2026 · PMID 42774363 · candidate dictionary pubmed

A quantitative treatment assessment for optimizing combined virotherapy-chemotherapy regimens against HPV-induced cervical cancer.

Salil Ghosh, Amit Kumar Bag, Satyajit Mukherjee et al. · PLoS One · Jan 1, 2026 · PMID 42766698 · candidate dictionary pubmed

Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation.

Lele Chang, Yaxin Kang, Mingxuan Zhu et al. · PLoS One · Jan 1, 2026 · PMID 42809552 · candidate dictionary pubmed

DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.

· Histopathology · 2016 · PMID 26033501 · validated civic_curation pubmed

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

· N Engl J Med · 2018 · PMID 30345884 · validated civic_curation pubmed

Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2.

· Gynecol Oncol · 2017 · PMID 28882436 · validated civic_curation pubmed

Diagnostic utility of PAX8 in differentiation of mullerian from non-mullerian tumors.

· Adv Biomed Res · 2014 · PMID 24800185 · validated civic_curation pubmed

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.

· N Engl J Med · 2016 · PMID 27717299 · validated civic_curation pubmed

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

· Nat Genet · 2014 · PMID 24658004 · validated cbioportal_study pubmed

Advanced ovarian cancer: what should be the standard of care?

· J Gynecol Oncol · 2013 · PMID 23346317 · validated civic_curation pubmed

Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer.

· Cancer · 2010 · PMID 20336784 · validated civic_curation pubmed

The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.

· Mod Pathol · 2010 · PMID 20693978 · validated civic_curation pubmed

XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer.

· Gynecol Oncol · 2006 · PMID 16875718 · validated civic_curation pubmed

ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.

· J Clin Oncol · 2009 · PMID 19470935 · validated civic_curation pubmed

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.

· Am J Obstet Gynecol · 2005 · PMID 15746676 · validated civic_curation pubmed